FDA advisory panel recommends conditional approval of first nonlaser surgical treatment for myopia Jan. 14, 1999
Senju reports synthesis and evaluation of compounds with multiple pharmacological actions Dec. 8, 1998
Photogen initiates development of ocular disease Rx; receives U.S. patents for technology Dec. 7, 1998
Olopatadine combination more effective than loratadine monotherapy in allergic conjunctivitis Nov. 27, 1998
RSS